AIMS: The present study examined the associations between early onset of non-medical use of prescription drugs (NMUPD) (i.e. sedatives, tranquilizers, opioids, stimulants) and the development of prescription drug abuse and dependence in the United States. DESIGN: Data were collected from structured diagnostic interviews using the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Alcohol Use Disorder and Associated Disabilities Interview Schedule: Diagnostic and Statistical Manual version IV (DSM-IV). SETTING: National prevalence estimates were derived from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC, n = 43,093). PARTICIPANTS: A nationally representative cross-sectional sample of civilian non-institutionalized adults aged 18 years or older in the United States, of whom 52% were women, 71% white, 12% Hispanic, 11% African American, 4% Asian and 2% Native American or of other racial background. FINDINGS: A higher percentage of individuals who began using prescription drugs non-medically at or before 13 years of age were found to have developed prescription drug abuse and dependence versus those individuals who began using at or after 21 years of age. Multivariate logistic regression analyses indicated that the odds of developing any life-time prescription drug abuse among non-medical users was reduced by approximately 5% with each year non-medical use was delayed [adjusted odds ratio (AOR) = 0.95, 95% CI = 0.94, 0.97], and that the odds of developing any life-time prescription drug dependence were reduced by about 2% with each year onset was delayed (AOR = 0.98, 95% CI = 0.96, 1.00) when controlling for relevant covariates. CONCLUSIONS: The results of this study indicate that early onset of NMUPD was a significant predictor of prescription drug abuse and dependence. These findings reinforce the importance of developing prevention efforts to reduce NMUPD and diversion of prescription drugs among children and adolescents.
AIMS: The present study examined the associations between early onset of non-medical use of prescription drugs (NMUPD) (i.e. sedatives, tranquilizers, opioids, stimulants) and the development of prescription drug abuse and dependence in the United States. DESIGN: Data were collected from structured diagnostic interviews using the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Alcohol Use Disorder and Associated Disabilities Interview Schedule: Diagnostic and Statistical Manual version IV (DSM-IV). SETTING: National prevalence estimates were derived from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC, n = 43,093). PARTICIPANTS: A nationally representative cross-sectional sample of civilian non-institutionalized adults aged 18 years or older in the United States, of whom 52% were women, 71% white, 12% Hispanic, 11% African American, 4% Asian and 2% Native American or of other racial background. FINDINGS: A higher percentage of individuals who began using prescription drugs non-medically at or before 13 years of age were found to have developed prescription drug abuse and dependence versus those individuals who began using at or after 21 years of age. Multivariate logistic regression analyses indicated that the odds of developing any life-time prescription drug abuse among non-medical users was reduced by approximately 5% with each year non-medical use was delayed [adjusted odds ratio (AOR) = 0.95, 95% CI = 0.94, 0.97], and that the odds of developing any life-time prescription drug dependence were reduced by about 2% with each year onset was delayed (AOR = 0.98, 95% CI = 0.96, 1.00) when controlling for relevant covariates. CONCLUSIONS: The results of this study indicate that early onset of NMUPD was a significant predictor of prescription drug abuse and dependence. These findings reinforce the importance of developing prevention efforts to reduce NMUPD and diversion of prescription drugs among children and adolescents.
Authors: Boji Huang; Deborah A Dawson; Frederick S Stinson; Deborah S Hasin; W June Ruan; Tulshi D Saha; Sharon M Smith; Risë B Goldstein; Bridget F Grant Journal: J Clin Psychiatry Date: 2006-07 Impact factor: 4.384
Authors: Christian J Teter; Sean Esteban McCabe; Kristy LaGrange; James A Cranford; Carol J Boyd Journal: Pharmacotherapy Date: 2006-10 Impact factor: 4.705
Authors: Bridget F Grant; Deborah A Dawson; Frederick S Stinson; S Patricia Chou; Mary C Dufour; Roger P Pickering Journal: Drug Alcohol Depend Date: 2004-06-11 Impact factor: 4.492
Authors: Sean Esteban McCabe; John E Schulenberg; Patrick M O'Malley; Megan E Patrick; Deborah D Kloska Journal: Addiction Date: 2013-10-22 Impact factor: 6.526
Authors: Lisa A Marsch; Sarah K Moore; Jacob T Borodovsky; Ramon Solhkhah; Gary J Badger; Shelby Semino; Kate Jarrett; Kathleen DiGangi Condon; Kate Rossettie; Phillip Vincent; Neda Hajizadeh; Elizabeth Ducat Journal: Addiction Date: 2016-04-21 Impact factor: 6.526
Authors: Raminta Daniulaityte; Russel Falck; Linna Li; Ramzi W Nahhas; Robert G Carlson Journal: Drug Alcohol Depend Date: 2011-08-31 Impact factor: 4.492
Authors: Carolyn F Wong; Karol Silva; Aleksandar Kecojevic; Sheree M Schrager; Jennifer Jackson Bloom; Ellen Iverson; Stephen E Lankenau Journal: Drug Alcohol Depend Date: 2013-02-28 Impact factor: 4.492
Authors: Margaret E Smith; Jay S Lee; Aaron Bonham; Oliver A Varban; Jonathan F Finks; Arthur M Carlin; Amir A Ghaferi Journal: Surg Endosc Date: 2018-10-23 Impact factor: 4.584
Authors: Joanna G Katzman; Chris Fore; Snehal Bhatt; Nina Greenberg; Julie Griffin Salvador; George C Comerci; Christopher Camarata; Lisa Marr; Rebecca Monette; Sanjeev Arora; Andrea Bradford; Denise Taylor; Jenny Dillow; Susan Karol Journal: Am J Public Health Date: 2016-05-19 Impact factor: 9.308